Can smokeless tobacco products satiate a smoker’s nicotine craving while simultaneously serving as a smoking cessation aid? And if so, is it conceivable that such a transition might result in net harm, paradoxical as that seems? These are the pivotal questions that Matthew Carpenter, an associate professor in the Department of Psychiatry and Behavioral Sciences and the Department of Medicine at the Medical University of South Carolina, aims to answer with his new year-long study on 1,250 smokers nationwide.
Can smokeless tobacco products satiate a smoker’s nicotine craving while simultaneously serving as a smoking cessation aid? And if so, is it conceivable that such a transition might result in net harm, paradoxical as that seems? These are the pivotal questions that Matthew Carpenter, an associate professor in the Department of Psychiatry and Behavioral Sciences and the Department of Medicine at the Medical University of South Carolina, aims to answer with his new year-long study on 1,250 smokers nationwide.